Biotech-Finances is the only European Newsletter written in French and dedicated to financial and economical aspects of biotech companies. Created in 1999 by « les Echos » Group and included in its product line for professionals it is today published by « les Editions Européennes de l'Innovation (EEI) ».
Leader within its sector, Biotech-Finances is available in printed and on line French versions (www.biotech-finances.com). It brings strategic information and analysis to the biotech, life sciences companies, institutional and financial analysts arising from all Europe.
Every Monday you will find in Biotech-Finances :
The major deals performed during the last week in France and Europe by the biotech companies (fundings, pharma-biotech and biotech-biotech deals, M&A...)
European biotech profiles followed by exclusive data on :
their business partners : banks, financial and IP counselors, lawyers, industrial and institutional partners
their updated business opportunities: partnering offers, in licensing, out licensing, suppliers research, equipment needs (material ; facilities ...)
their international competitors based on a wide screening of drugs in the same therapeutic area (Exclusive from: Biotech-finances / Lifescience consulting)
startegical advices from financial, IP and law experts...
Biotech-Finances also publishes :
The BIOMAP ® : a map published in partnering with « Invest In France » which index synthetically the major French biotechs including pertinent informations (employees number, CEO's name, key financial information).
The journal €deals Biotech, an European and biannual publication listing in exclusiveness biotech deals, financial analysts and opinions leaders comments in 25 European countries plus Israel.
In April 2006 during the BIO Chicago conference
Biotech-Finances launched www.biolifetv.com
the first internetTV dedicated to the
actors of the life sciences sector.
Biotech-Finances - 72 bd des Brotteaux 69006 Lyon - France
Publisher - Jacques-Bernard TASTE
jbtaste@biotech-finances.com / tél. +33 (0)478 24 35 20
|